Trial intelligence / Profile preview

Cooled Radiofrequency vs. Intraarticular Injection for Chronic Hip Pain

NCT03985280Phase 4Unknown

Start
Jun 2018
Primary completion
Jun 2020
Countries
1
01

Overview

Phase 4, randomised, open-label trial in chronic hip pain and hip osteoarthritis (2 arms). Primary endpoints: Percentage of subjects with Visual Analog Scale reduction greater than 50% at 3 months and Persistence of clinical effect (VAS reduction > 50%) at 6 months. Status: unknown.

02

Conditions

chronic hip painhip osteoarthritis

Beyond the preview

Go deeper on NCT03985280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03985280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call